Implementation of measures to prevent recurrence of improper accounting
First written in FY2022. 4 of 6 entries say "Restated". Latest entry: FY2024-Q2.
7 other companies' latest entry also says "Restated".
- FY2024-Q2RestatedAnnual report
「① Strict compliance and stronger governance」
The company continues to prioritize thorough compliance and stronger governance in response to the inappropriate accounting as key initiatives for the first year. - FY2023AdvancedAnnual report
「Recurrence Prevention Committee working to improve management in response to last year’s inappropriate accounting case」
The company identifies the Recurrence Prevention Committee, concerning measures to prevent recurrence following the correction of prior-period financial statements, as an organization for sustainability and governance. - FY2023-Q3RestatedAnnual report
「① Strict compliance (preventing recurrence of misconduct and eliminating harassment), foremost among them」
The company continues to prioritize preventing a recurrence of misconduct following the correction of prior-period financial statements as its leading compliance initiative. - FY2023-Q2RestatedAnnual report
「① Strict compliance (preventing recurrence of misconduct and eliminating harassment), foremost among them」
The company continues to prioritize preventing a recurrence of misconduct following the correction of prior-period financial statements as its leading compliance initiative. - FY2023-Q1RestatedAnnual report
「① Strict compliance (preventing recurrence of misconduct and eliminating harassment), foremost among them」
The company continues to prioritize preventing a recurrence of misconduct following the correction of prior-period financial statements as its leading compliance initiative. - FY2022First statedAnnual report
「Based on these developments, we are proceeding with measures to prevent recurrence as described in the “Notice Concerning the Formulation of Measures to Prevent Recurrence” dated 1 September 2022.」
The company states for the first time that it is proceeding with the measures to prevent recurrence announced on 1 September 2022, following the correction of prior-period financial statements.